Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (90) clinical trials

Study to evaluate the long-term safety and efficacy of Darbepoetin Alfa in anemic subjects with Advanced Stage Non-small Cell Lung Cancer receiving multi-cycle chemotherapy. Patient Inclusion Criteria: Subjects with metastatic (stage IV) Non-small Cell Lung cancer, receiving or about receive first line cyclic chemotherapy, life expectancy >6 months, 18 years ...

Phase

Patients with non-small cell lung cancer who have failed two or more prior treatment regimens, to determine overall survival Patient Inclusion Criteria: 18+ years of age, confirmed stage IIIB or non-small cell lung cancer, failed at least 2 prior systemic anti-cancer regimens, disease progression, Patient Exclusion Criteria: Presence of brain ...

Phase

First-line induction and maintenance therapy for the treatment of patients with Stage IV NSCLC Patient Inclusion Criteria: Must have a histologic or cytologic diagnosis of advance NSCLC, may not have received any prior systemic chemotherapy, 18 + years of age Patient Exclusion Criteria: Have a known central nervous system disease, ...

Phase

For more information please visit: http://clinicaltrials.gov/ct2/show/record/NCT00632853?term=30610&rank=1

Phase

The purpose of this research study is to compare any good and bad effects of using the study drug, crizotinib (also known as XALKORI®), after completion of surgery and, in some cases, after chemotherapy and/or radiation therapy for ALK-positive non-small cell lung cancer. The addition of crizotinib may help prevent ...

Phase

The primary efficacy objective of the study is to evaluate the efficacy of 16 cycles of Atezolizumab (MPDL3280A) treatment compared with best supportive care as measured by disease-free survival (DFS) as assessed by the investigator.

Phase

This randomized, open-label study will evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin and paclitaxel with or without bevacizumab compared with treatment with carboplatin plus (+) paclitaxel and bevacizumab in chemotherapy-naïve patients with Stage IV non-squamous non-small cell lung cancer (NSCLC).

Phase

The purpose of this study is to determine whether AZD9291 may be more effective than standard therapy in extending the time before your lung cancer gets worse.

Phase

The purpose of this study is to test the effectiveness (how well the drug works), safety, and tolerability of an investigational drug called nivolumab (also known as BMS-936558) in subjects with Small Cell Lung Cancer (SCLC). BMS would like to find out from this study if nivolumab or nivolumab with ...

Phase

The main purpose of this study is to see if nivolumab on its own in combination with ipilimumab or in combination with chemotherapy is better at improving your chances of survival and at delaying the worsening of your lung cancer (called progression) when compared to standard chemotherapy treatment. This study ...

Phase